ReviewCancer medicine2023

Plasma D-dimer and interleukin-6 are associated with treatment response and progression-free survival in advanced NSCLC patients on anti-PD-1 therapy.

Chong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.